Schrödinger makes significant investments in R&D, which has led to major advances in the field of computational chemistry. Working closely with its scientific advisory board – a distinguished group of leading academic and industrial scientists who collectively have thousands of publications, many of which represent groundbreaking advances – Schrödinger has achieved breakthroughs in quantum chemistry, molecular modeling, force fields, molecular dynamics, protein structure determination, scoring, and virtual screening. Schrödinger's methods development and applications papers have thousands of citations and are often among the most-cited scientific publications. Schrödinger's science is continually validated internally and by its users worldwide.
The company's full product offerings range from general molecular modeling programs to a comprehensive suite of drug design software, as well as a state-of-the-art suite for materials research. Schrödinger is developing enterprise level software that can be deployed throughout an entire research organization, and the company is committed to providing integrated software solutions and services that truly meet its customers’ needs. Schrödinger wants to empower researchers around the world to achieve their goals of improving human health and quality of life through advanced computational techniques that transform the way chemists design compounds and materials. By building and deploying breakthrough scientific software solutions and forming collaborations and partnerships, Schrödinger helps scientists accelerate their research and development activities, reduce costs, and make novel discoveries that might otherwise not be possible.
Founded in 1990, Schrödinger has operations in several locations within the United States as well as in Europe, India, and Japan.